We assessed the performance of genotypic algorithms for predicting the tropism of HIV-1
Human immunodeficiency virus type 1 (HIV-1) enters target cells through the sequential binding of the envelope glycoprotein (gp120) to CD4 and a chemokine receptor, CCR5 or CXCR4 (1) . HIV-1 coreceptor usage must be identified before treatment with CCR5
antagonists, as they can only be used for patients harbouring R5 viruses alone (7) . The gold standard for characterizing HIV-1 tropism is a recombinant virus phenotypic entry assay, but 5 genotypic methods based on the V3 sequence could be easier. We have previously shown that the V3 genotype accurately predicts the phenotype of HIV-1 coreceptor usage for subtype B viruses (5, 13) . But the V3-based genotypic algorithms could be unsuitable for predicting the tropism of non-B viruses because they were built using data sets of genotype-phenotype correlations from subtype B viruses (9) . Indeed, the Geno2Pheno and the WebPSSM 10 algorithms were not designed to be predictive for non-B viruses, except a recent version of the PSSM designed for subtype C viruses (11, 12) . It is thus necessary to study subtype-specific genotypic determinants of HIV-1 tropism. The CRF02-AG recombinant subtype predominates in West Africa (10) A region spanning the gp120 and the ectodomain of the gp41 env gene of plasma HIV-1 RNA was amplified by RT-PCR. Two separate PCR amplifications were performed in parallel for each patient and pooled to prevent sampling bias of the assessed virus population.
The V3 region from the env PCR product was bulk sequenced, blinded to the phenotype, as 10 previously described (13) . Bulk sequencing allows the detection of minor variants when present at a frequency of at least 20% in the viral population. The phenotype of HIV-1 coreceptor usage was determined using a recombinant virus entry assay (13) . The sensitivity of the assay has been enhanced to detect minor amounts of CXCR4-using virus when they accounted for 0.5-1% of the virus population (data not shown). 15 We used a genotypic rule based on amino-acid residues at positions 11 and 25 and the to 87%). The combined 11/25 and net charge rule criteria successfully detected CRF02-AG subtype CXCR4-using viruses with a sensitivity of 70% and a specificity of 98%. 15
Geno2pheno lacked sensitivity (40%), while PSSM X4/R5 was sensitive (80%) but less specific (76%).
A recent study reported that the genotypic algorithms currently used lack sensitivity for detecting CXCR4-using viruses among non-B subtypes, but no details were given of their performance for particular subtypes (9) . Subtype-specific genotype-phenotype correlations 20 should be assessed because the genotypic determinants of coreceptor usage for some particular subtypes may be different. We found that the Geno2pheno tool lacked sensitivity for predicting the CXCR4 usage of subtype CRF02-AG viruses, although it performs well for subtype B viruses (13) . In contrast, the combined 11/25 and net charge rule criteria were equally good at predicting the CXCR4 usage of both subtype CRF02-AG and subtype B 25 
